Free Republic

If I had the opportunity to go back in time, knowing what I know now, I would reconsider the decision regarding the "special operation" in Ukraine, Russian President Vladimir Putin said during his annual press conference, APA's Moscow correspondent reports. that this was stated by Russian President Vladimir Putin during his annual press conference. He emphasized that preparation was needed before launching the "special operation": "But we began the operations without any special preparation.

Russian President Vladimir Putin said on Thursday that he was ready to compromise over Ukraine in possible talks with US President-elect Donald Trump on ending the war and had no conditions for starting talks with the Ukrainian authorities, News.az reports citing Reuters. -snip- Putin, fielding questions on state TV during his annual question and answer session with Russians, told a reporter for a US news channel that he was ready to meet Trump, whom he said he had not spoken to for years. Asked if he'd do anything differently, he said he should have sent troops into Ukraine sooner than...

Russian President Vladimir Putin has commented on U.S. President Joe Biden pardoning his son, Hunter Biden, APA's Moscow correspondent reports. During a year-end press conference, Putin said he does not criticize Biden for pardoning his son. "Biden pardoned his son, even though he had said he wouldn't. When discussing Biden, one must consider that he is a politician. The important question is which trait of his dominates—politics or humanity. It seems humanity prevails in Biden. I wouldn’t criticize him for that," the Russian leader emphasized. Putin compared Hunter Biden's pardon to Stalin's decision not to exchange his captured son.

Russia has developed an mRNA-based vaccine aimed at combating cancer. The vaccine, developed in collaboration with multiple research centres, is set to be distributed free of cost to cancer patients, as announced by Andrey Kaprin, General Director of the Radiology Medical Research Center under the Russian Ministry of Health. This vaccine is expected to be released for public use by early 2025. Pre-clinical trials have already demonstrated its efficacy in suppressing tumour development and preventing potential metastases, according to Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology. mRNA vaccines work by delivering specific instructions to...